Hedda Magnusson

ASCRO at Nordic Life Science Days Sep 2018

ASCRO attended the Nordic Life Science Days in Stockholm 11-12Sep2018 with a number of representatives being present both from the board of ASCRO and from member companies. Discussions were held with potential new members, but also with other parties such as different companies within drug development and organisations such as Sweden Bio. There are many…

ASCRO attending 6th Nordic Conference on Clinical Trials, Helsinki, October 2017

ASCRO attended the 6th Nordic Conference on Clinical Trials in Helsinki, October 25-26 2017. The conference was focused on the new regulations for both clinical trials on medical products and medical devices. Different speakers from both authorities, pharma industry, healthcare and academia presented different topics around the regulations and the current preparations that are ongoing,…

ASCRO represented at the National Conference on Clinical Studies in September 2017

ASCRO participated with a booth at the annual, national conference on clinical studies, this year arranged by “Kliniska Studier Sverige” (KSS) and KTA in Stockholm. Approximately 650 people attended the conference, mostly from healthcare/academia, but also from pharmaceutical industry and CROs. The representatives from ASCRO interacted with many representatives both from the member companies, industry…

Members’ meeting with MPA update

A members’ meeting was held in Stockholm on 12Jun17 during which Catharina Forzelius, from the Swedish MPA, informed about the preparations that are ongoing for the new EU legislation around clinical trials. She also informed ASCRO about the new test-portal and procedure for applications for clinical trials. After this, Christina Forselius, chair of te board, discussed the new…

ASCRO confirms associated membership in LIF

LIF, branschorganisationen för forskande läkemedelsföretag i Sverige och ASCRO, branschorganisationen för CRO-företag har ingått ett associationsavtal vilket innebär att organisationerna och dess medlemsföretag knyts närmare varandra. – Den forskande läkemedelsbranschen stärks av samarbetet då vi, tillsammans med ASCRO, företräder en stor del av den företagsfinansierade och patientnära forskningen, säger Anders Blanck, VD för LIF. –…